Zobrazeno 1 - 10
of 12
pro vyhledávání: '"T F, Reiss"'
Publikováno v:
Allergologie. 28:343-354
Objective: The objective of this study was to evaluate montelukast 10 mg daily as treatment for allergic rhinitis in patients with symptomatic allergic rhinitis and active asthma during the allergy season. Methods: This was a multicenter study of 831
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b642362a1c6f68ef2c5a7b1cae86801
https://doi.org/10.5414/alp28343
https://doi.org/10.5414/alp28343
Autor:
I. Aziz, R. Adachi, J. A. Nelson, E. R. McFadden, Brian J. Lipworth, P. K. Honig, D. A. Stempei, J. Hansen Flaschen, Louise Strauss, J. K. Jenkins, T. F. Reiss, Burton F. Dickey
Publikováno v:
New England Journal of Medicine. 339:1783-1786
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54385483b826d63aa7dd18c660312dbc
https://doi.org/10.1056/nejm199812103392412
https://doi.org/10.1056/nejm199812103392412
Publikováno v:
European Respiratory Journal. 10:646-651
The measurement characteristics of two asthma symptom diary scales developed for use as health outcome measures in clinical trials of asthma therapy were investigated. A daytime diary scale was designed to capture the frequency and inconvenience of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::376b267d72e75c76d53a4a1adb32bf68
https://doi.org/10.1183/09031936.97.10030646
https://doi.org/10.1183/09031936.97.10030646
Autor:
G, Philip, K, Malmstrom, F C, Hampel, S F, Weinstein, C F, LaForce, P H, Ratner, M-P, Malice, T F, Reiss
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 32(7)
Cysteinyl leukotrienes are important proinflammatory mediators believed to have a role in allergic rhinitis.This multicentre, randomized, double-blind, placebo- and active-controlled trial evaluated the effectiveness and tolerability of montelukast,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b85680520113e3643d1b0a1f26bd6ce9
https://pubmed.ncbi.nlm.nih.gov/12100048
https://pubmed.ncbi.nlm.nih.gov/12100048
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 31(6)
Leukotriene receptor antagonists have demonstrated clinical benefits in chronic asthma studies of up to 3 months in duration. The effects of these agents over extended periods of time have not been reported.To describe the long-term effect of oral mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c90db07d541d18c45d1948ece74a09c
https://pubmed.ncbi.nlm.nih.gov/11422148
https://pubmed.ncbi.nlm.nih.gov/11422148
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 31(1)
Montelukast is a leukotriene receptor antagonist administered orally once daily for treatment of chronic asthma in adults and children. A comprehensive analysis of safety data from double-blind, randomized, placebo-controlled trials with montelukast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60e24421802aff092dde855cb5ae1bfe
https://pubmed.ncbi.nlm.nih.gov/11167954
https://pubmed.ncbi.nlm.nih.gov/11167954
Autor:
M, Laviolette, K, Malmstrom, S, Lu, P, Chervinsky, J C, Pujet, I, Peszek, J, Zhang, T F, Reiss
Publikováno v:
American journal of respiratory and critical care medicine. 160(6)
The primary objective of this study was to determine whether montelukast, an oral leukotriene receptor antagonist, provides additional clinical benefit to the effect of inhaled corticosteroids. A total of 642 patients with chronic asthma (FEV(1) 50 t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee2e40bb34807a43fd74627ec33789c1
https://pubmed.ncbi.nlm.nih.gov/10588598
https://pubmed.ncbi.nlm.nih.gov/10588598
Autor:
K, Malmstrom, G, Rodriguez-Gomez, J, Guerra, C, Villaran, A, Piñeiro, L X, Wei, B C, Seidenberg, T F, Reiss
Publikováno v:
Annals of internal medicine. 130(6)
Oral leukotriene receptor antagonists have been shown to have efficacy in chronic asthma.To compare the clinical benefit of montelukast, a once-daily oral leukotriene receptor antagonist; placebo; and inhaled beclomethasone.Randomized, double-blind,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0eb9f31b33b2b5638659f4f5174f5a0f
https://pubmed.ncbi.nlm.nih.gov/10610635
https://pubmed.ncbi.nlm.nih.gov/10610635
Publikováno v:
The Journal of allergy and clinical immunology. 102(1)
The cysteinyl leukotrienes are important mediators of bronchial asthma. The clinical effect of montelukast, a potent cysteinyl leukotriene-receptor antagonist, was investigated in a randomized, placebo-controlled, multicenter, parallel-group, dose-ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a38afc93e2e009d7e9fd2a0d0911f5e2
https://pubmed.ncbi.nlm.nih.gov/9679847
https://pubmed.ncbi.nlm.nih.gov/9679847
Publikováno v:
Archives of internal medicine. 158(11)
To determine the clinical effect of oral montelukast sodium, a leukotriene receptor antagonist, in asthmatic patients aged 15 years or more.Randomized, multicenter, double-blind, placebo-controlled, parallel-group study. A 2-week, single-blind, place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4495eb8dd95485fb3447ad4f2ce17b7c
https://pubmed.ncbi.nlm.nih.gov/9625400
https://pubmed.ncbi.nlm.nih.gov/9625400